December 14, 2024 01:51 (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
Bengaluru techie suicide: Karnataka Police issues summons to wife Nikita, her family members | French President Macron appoints centrist leader Francois Bayrou as new Prime Minister | Congress always prioritised personal interest over Constitution: Rajnath Singh | Jaishankar calls attack on Hindus in Bangladesh 'a source of concern' | Allu Arjun arrested over woman's death in stampede during Pushpa 2 premiere show | RBI receives bomb threat in Russian language, case filed | UP teenager kills mother, lives with body for 5 days | At least six people including a child killed in Tamil Nadu hospital fire | Amid Atul Subhash row, SC says mere harassment is not enough to prove abetment to suicide | India's D Gukesh becomes youngest ever world champion in chess
India crosses the milestone of conducting 400 million Covid tests

India crosses the milestone of conducting 400 million Covid tests

Jun 27, 2021, at 01:22 am

New Delhi/IBNS: India crossed the milestone of 400 million Covid-19 tests on Friday, with the last 50 million tests being done in the last 24 days, according to the Indian Council of Medical Research (ICMR).

People in England to be offered twice-weekly rapid COVID-19 tests: UK Prime Minister

People in England to be offered twice-weekly rapid COVID-19 tests: UK Prime Minister

Apr 05, 2021, at 11:23 pm

London/Sputnik: People in England will be offered rapid COVID-19 tests twice a week from April 9, as part of the UK government's plan to stop the spread of the coronavirus SARS-CoV-2 and reopen business and society, UK Prime Minister Boris Johnson announced on Monday.

New COVID-19 test gives result in matter of minutes: Report

New COVID-19 test gives result in matter of minutes: Report

Jan 05, 2021, at 09:12 pm

London: A new COVID-19 test that reduces testing time from 30 minutes to less than five and delivers accurate results has been developed by researchers at the University of Birmingham.

DCGI approves Tata Group's low cost CRISPR Covid-19 test 'Feluda'

DCGI approves Tata Group's low cost CRISPR Covid-19 test 'Feluda'

Sep 21, 2020, at 07:55 am

Delhi/IBNS: The Drugs Controller General of India (DCGI) has given its approval for the commercial launch of India's first Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR), Covid-19 test 'Feluda' developed by the Tata Group and CSIR-IGIB (Institute of Genomics and Integrative Biology).